Teva Pharmaceutical Industries Ltd. has completed its cash acquisition, of Pfizer's Italian generic pharmaceutical marketing company, Dorom S.r.l., one of the largest suppliers of generic pharmaceuticals to the Italian retail market.

Teva Italy will integrate Dorom's business into its own pharmaceutical activities and will actively promote the product lines of both companies.

Subsequent to this acquisition, Teva, which is the largest generic company in Italy, will further strengthen its leading position in this important and growing market. The combined company, Teva Italy, will have a product portfolio of 77 generic products (in 150 presentations) available to the Italian market and 63 products in the pipeline (in 122 presentations) of pending generic product registrations, the company said in a release.